Literature DB >> 25673773

Suppression of discoidin domain receptor 1 expression enhances the chondrogenesis of adipose-derived stem cells.

Shun-Cheng Wu1, Hsu-Feng Hsiao2, Mei-Ling Ho1, Yung-Li Hung3, Je-Ken Chang4, Gwo-Jaw Wang5, Chau-Zen Wang6.   

Abstract

Effectively directing the chondrogenesis of adipose-derived stem cells (ADSCs) to engineer articular cartilage represents an important challenge in ADSC-based articular cartilage tissue engineering. The discoidin domain receptor 1 (DDR1) has been shown to affect cartilage homeostasis; however, little is known about the roles of DDR1 in ADSC chondrogenesis. In this study, we used the three-dimensional culture pellet culture model system with chondrogenic induction to investigate the roles of DDR1 in the chondrogenic differentiation of human ADSCs (hADSCs). Real-time polymerase chain reaction and Western blot were used to detect the expression of DDRs and chondrogenic genes. Sulfated glycosaminoglycan (sGAG) was detected by Alcian blue and dimethylmethylene blue (DMMB) assays. Terminal deoxy-nucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining was used to assess cell death. During the chondrogenesis of hADSCs, the expression of DDR1 but not DDR2 was significantly elevated. The depletion of DDR1 expression in hADSCs using short hairpin RNA increased the expression of chondrogenic genes (SOX-9, collagen type II, and aggrecan) and cartilaginous matrix deposition (collagen type II and sGAG) and only slightly increased cell death (2-8%). DDR1 overexpression in hADSCs decreased the expression of chondrogenic genes (SOX-9, collagen type II, and aggrecan) and sGAG and enhanced hADSC survival. Moreover, DDR1-depleted hADSCs showed decreased expression of the terminal differentiation genes runt-related transcription factor 2 (Runx2) and matrix metalloproteinase 13 (MMP-13). These results suggest that DDR1 suppression may enhance ADSC chondrogenesis by enhancing the expression of chondrogenic genes and cartilaginous matrix deposition. We proposed that the suppression of DDR1 in ADSCs may be a candidate strategy of genetic modification to optimize ADSC-based articular cartilage tissue engineering.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  ADSCs; DDR1; adipose-derived stem cells; articular cartilage tissue engineering; chondrogenesis; discoidin domain receptor 1

Mesh:

Substances:

Year:  2015        PMID: 25673773     DOI: 10.1152/ajpcell.00398.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  5 in total

1.  Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway.

Authors:  Yi-Lin Zhang; Fen Liu; Zhi-Bang Li; Xiao-Tao He; Xuan Li; Rui-Xin Wu; Hai-Hua Sun; Shao-Hua Ge; Fa-Ming Chen; Ying An
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

2.  Discoidin Domain Receptor-1 Regulates Calcific Extracellular Vesicle Release in Vascular Smooth Muscle Cell Fibrocalcific Response via Transforming Growth Factor-β Signaling.

Authors:  Jona B Krohn; Joshua D Hutcheson; Eduardo Martínez-Martínez; Whitney S Irvin; Carlijn V C Bouten; Sergio Bertazzo; Michelle P Bendeck; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-21       Impact factor: 8.311

3.  Simvastatin Enhances the Chondrogenesis But Not the Osteogenesis of Adipose-Derived Stem Cells in a Hyaluronan Microenvironment.

Authors:  Shun-Cheng Wu; Chih-Hsiang Chang; Ling-Hua Chang; Che-Wei Wu; Jhen-Wei Chen; Chung-Hwan Chen; Yi-Shan Lin; Je-Ken Chang; Mei-Ling Ho
Journal:  Biomedicines       Date:  2021-05-17

Review 4.  Effects of matrix metalloproteinases on the fate of mesenchymal stem cells.

Authors:  Sami G Almalki; Devendra K Agrawal
Journal:  Stem Cell Res Ther       Date:  2016-09-09       Impact factor: 6.832

5.  miR-1307-3p suppresses the chondrogenic differentiation of human adipose-derived stem cells by targeting BMPR2.

Authors:  Zhen Yang; Rui Li; Jun Ao; Qing-De Wa; Yi Zhang; Long Chen; Jing Wen; Biao Chen; Wei Pan; Bo Li; Xiao-Bin Tian
Journal:  Int J Mol Med       Date:  2018-09-21       Impact factor: 4.101

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.